CollPlant Biotechnologies Ltd Stock-Based Compensation
CollPlant Biotechnologies Ltd (CLGN) reported Stock-Based Compensation of $999.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-03-26
| Period end | Share-based Payment Arrangement, Noncash Expense 0 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $999.00K 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $735.00K 6-K · filed 2025-08-20 | ||
| 2024-12-31 | $1.72M 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $780.00K 6-K · filed 2025-08-20 | ||
| 2023-12-31 | $1.94M 20-F · filed 2026-03-26 | ||
| 2022-12-31 | $2.17M 20-F · filed 2025-03-26 | ||
| 2021-12-31 | $1.60M 20-F · filed 2024-04-04 | ||
| 2019-12-31 | $871.00K 20-F · filed 2021-03-26 |